Extract
Acorda Therapeutics Announces $31.5 Million Financing.
HAWTHORNE, N.Y. -- Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that it has entered into a definitive purchase agreement with certain investors to r...
See the full content of this document
Sponsored links
